Dr Friedberg reviews the practical implications of the GADOLIN study, as well as the current and future advancements that will be seen in the use of newer and older medications, autologous stem cell transplantation, as well as a potential future in precision medicine for the treatment of follicular lymphoma. For more resources and information regarding anticancer targeted therapies:
0 Comments